Literature DB >> 17803746

Pharmacokinetics and pharmacodynamics of a single dose of zoledronate in healthy dogs.

T Martín-Jiménez1, L-P De Lorimier, T M Fan, K J Freise.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17803746     DOI： 10.1111/j.1365-2885.2007.00883.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN： 0140-7783            Impact factor:   1.786


× No keyword cloud information.
  2 in total

1.  Bisphosphonates significantly increase the activity of doxorubicin or vincristine against canine malignant histiocytosis cells.

Authors:  S D Hafeman; D Varland; S W Dow
Journal:  Vet Comp Oncol       Date:  2011-05-18       Impact factor: 2.613

2.  Effect of timing of bisphosphonate administration on canine osteosarcoma cells undergoing radiation therapy.

Authors:  Katie Hoddinott; Michelle L Oblak; Geoffrey A Wood; Sarah Boston; Anthony J Mutsaers
Journal:  Can J Vet Res       Date:  2020-07       Impact factor: 1.310
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.